You have 9 free searches left this month | for more free features.

19-479

Showing 9976 - 10000 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Bacterial Resistance Trial in Loma Linda (Ciprofloxacin, Standard Aseptic Technique)

Completed
  • Bacterial Resistance
  • Loma Linda, California
    Loma Linda University of Health Sciences Faculty Medical Offices
Oct 29, 2017

Advanced Squamous NSCLC Trial in United States (AMG 479, Carboplatin, Paclitaxel)

Terminated
  • Advanced Squamous Non-Small Cell Lung Cancer
  • AMG 479
  • +2 more
  • Fayetteville, Arkansas
  • +25 more
Mar 27, 2017

Scalp Blood Flow and Hair Shaft In Premenopausal Women Versus

Completed
  • Healthy
    • Winston-Salem, North Carolina
      Wake Forest School of Medicine - Dermatology Clinic
    Jul 3, 2018

    Infections, Papillomavirus Trial in Worldwide (Cervarix™, Havrix™-based investigational formulation)

    Completed
    • Infections, Papillomavirus
    • Cervarix™
    • Havrix™-based investigational formulation
    • Birmingham, Alabama
    • +137 more
    Jul 2, 2018

    Descriptive Epidemiology on Management of Mucormycosis

    Completed
    • Mycoses
      • New Delhi, Delhi, India
      • +12 more
      Feb 8, 2018

      Diabetes, Type 1 Trial in Bronx (Placebo and Insulin monotherapy via CL, Sitagliptin and insulin/novolog via CL)

      Completed
      • Diabetes Mellitus, Type 1
      • Placebo and Insulin monotherapy via CL
      • Sitagliptin and insulin/novolog via CL
      • Bronx, New York
        Albert Einstein College of Medicine CRC
      Jul 30, 2018

      Aging Trial in San Mateo (Plasma Transfusion)

      Unknown status
      • Aging
      • Plasma Transfusion
      • San Mateo, California
        The Infusion Center & Clinic
      Jan 14, 2018

      Alzheimer's Disease Trial in Worldwide (Rosiglitazone Extended Release 2mg, Rosiglitazone Extended Release 8mg, Placebo)

      Completed
      • Alzheimer's Disease
      • Rosiglitazone Extended Release 2mg
      • +2 more
      • Sun City, Arizona
      • +193 more
      Aug 3, 2017

      Mental Disorder Trial (PROTECT+)

      Unknown status
      • Mental Disorder
      • PROTECT+
      • (no location specified)
      Jun 27, 2018

      Opioid Use Disorder Trial in Overland Park (Buprenorphine, buprenorphine and naloxone, hydromorphone)

      Completed
      • Opioid Use Disorder
      • Overland Park, Kansas
        Vince & Associates Clinical Research
      Apr 23, 2018

      Prostate Cancer, Prostatic Tumors Trial in United States (Panobinostat, Bicalutamide)

      Completed
      • Prostate Cancer
      • Prostatic Neoplasms
      • New Brunswick, New Jersey
      • +3 more
      Jan 10, 2018

      Adverse Reaction to Diagnostic Agents and Kits Nos Trial in London (19F Cell Sense-labeled PBMC, MRI)

      Not yet recruiting
      • Adverse Reaction to Diagnostic Agents and Kits Nos
      • 19F Cell Sense-labeled PBMC
      • MRI
      • London, Ontario, Canada
        Robarts Research Institute
      May 22, 2018

      Obesity, Childhood, Asthma in Children, Inflammatory Response Trial in New Orleans (Lifestyle counseling)

      Completed
      • Obesity, Childhood
      • +9 more
      • Lifestyle counseling
      • New Orleans, Louisiana
        Louisiana State University Health Sciences Center
      Aug 21, 2018

      Carcinoma of the Prostate Trial in Toronto (HDR 2 Fraction, HDR 1 Fraction)

      Unknown status
      • Carcinoma of the Prostate
      • HDR 2 Fraction
      • HDR 1 Fraction
      • Toronto, Ontario, Canada
        Odette Cancer Centre, Sunnybrook Health Sciences Centre
      Apr 16, 2018

      Urinary Bladder, Overactive Trial in Worldwide (Mirabegron, Tolterodine, Placebo to Mirabegron)

      Completed
      • Urinary Bladder, Overactive
      • Homewood, Alabama
      • +307 more
      Nov 9, 2017

      Asthma Trial in Germany, United Kingdom (LAS100977 0.313 µg, LAS100977 0.625 µg, LAS100977 1.25 µg)

      Completed
      • Asthma
      • LAS100977 0.313 μg
      • +6 more
      • Berlin, Germany
      • +8 more
      May 7, 2018

      Pulmonary Disease, Chronic Obstructive Trial in Worldwide (GW642444, Placebo)

      Completed
      • Pulmonary Disease, Chronic Obstructive
      • Camperdown, New South Wales, Australia
      • +13 more
      Mar 7, 2018

      The State of Play in Picardy of Knowledge of Elderly at Risk of

      Completed
      • Knowledge, Attitudes, Practice
      • Elderly
      • Assess the state of knowledge of the subjects falling or at risk, their risk of recurrence or first episode, compared to medical knowledge.
      • Amiens, Picardie, France
        CHU Amiens Picardie
      Aug 7, 2018

      MPN (Myeloproliferative Tumors) Trial in Australia, Canada, United States (Ruxolitinib, Placebo)

      Completed
      • MPN (Myeloproliferative Neoplasms)
      • Birmingham, Alabama
      • +111 more
      Feb 12, 2018

      Epidural Steroid Analgesia on Functional MRI for LBP

      Completed
      • Chronic Low Back Pain
        • Tainan City, Shengli Rd, Taiwan
          National Cheng Kung University Hospital
        Jun 16, 2018

        Body Weight, Vibration, Motor Activity Trial in Alcorcón (Whole-body vibration (WBV))

        Completed
        • Body Weight
        • +2 more
        • Whole-body vibration (WBV)
        • Alcorcón, Madrid, Spain
          Universidad Rey Juan Carlos
        Nov 26, 2017

        Pulmonary Disease, Chronic Obstructive Trial in Worldwide (fluticasone furoate (FF), vilanterol (VI), umeclidinium bromide

        Completed
        • Pulmonary Disease, Chronic Obstructive
        • fluticasone furoate (FF)
        • +2 more
        • Athens, Alabama
        • +998 more
        Sep 11, 2018

        The Role of Visfatin in Obesity and Periodontal Disease

        Completed
        • Obesity
        • Periodontitis
        • Phase I Periodontal therapy
        • Metabolic control
        • Ankara, Turkey
          Gazi University Faculty of Dentistry
        Mar 20, 2018

        Multiple Myeloma, Multiple Myeloma in Relapse Trial (Perifosine, Bortezomib, Dexamethasone)

        Completed
        • Multiple Myeloma
        • Multiple Myeloma in Relapse
        • (no location specified)
        Feb 20, 2018

        Healthy Trial in Montréal (Maraviroc (5 days), Maraviroc and boceprevir (14 days))

        Completed
        • Healthy
        • Maraviroc (5 days)
        • Maraviroc and boceprevir (14 days)
        • Montréal, Quebec, Canada
          Centre Hospitalier de l'Université de Montréal
        Jan 24, 2018